Venus Medtech Announces the Addition of Two Cardiovascular Experts to Their Advisory Team

HANGZHOU, China, Jan. 20, 2020 -- (Healthcare Sales & Marketing Network) -- The leading transcatheter heart valve medical device player in China - Venus Medtech (Hangzhou) Inc. ("Venus Medtech" or the "Company", stock code: 2500.HK), t... Devices, Interventional, Cardiology, Personnel Venus Medtech, transcatheter heart valve, VenusA-Valve
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news